← Open Payments lookup

FATIMA SATTAR: Open Payments

NPI 1184087967 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$615 in 28 payments from 9 companies in 2025. Trend: 2023 $1,020 · 2024 $591 · 2025 $615

Food & beverage: $615
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$151
E.R. Squibb & Sons, L.L.C.3$150
Otsuka America Pharmaceutical, Inc.3$80
Neurocrine BioSciences, Inc.3$76
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$57
Alkermes, Inc.2$48
Axsome Therapeutics, Inc.1$20
Lundbeck LLC1$17
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: COBENFY, UZEDY, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, REXULTI, AUSTEDO XR, ARISTADA.

Industry payments across PA — which companies pay providers there.